Latest news - Novo Nordisk
WEB10 July 2024. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec. Read more. News archive. Featured stories. PRODUCTION. Expanding our fill-finish capacity.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
WEBApr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
Company announcements and press releases - Novo Nordisk
WEBNovo Nordisk to present new cardiovascular data at the 47th annual congress of the European Society of Cardiology, 30 August – 2 September, London, UK. Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024.
Novo Nordisk to boost output of Wegovy, Ozempic with new NC …
WEBJun 24, 2024 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy ...
Novo Nordisk expects double-digit growth as it boosts Wegovy …
WEBCOPENHAGEN/LONDON, Jan 31 (Reuters) - Novo Nordisk on Wednesday forecast another year of double-digit growth as the Danish drugmaker began boosting U.S. supplies of its popular weight-loss drug...
Novo Nordisk Wegovy approved for cutting heart disease risks
WEBMar 8, 2024 · The Food and Drug Administration approved Novo Nordisk’s blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in people with obesity and heart ...
News & media - Novo Nordisk
WEBNews & media. Get an overview of the Novo Nordisk press releases here or subscribe to our news and get it directly in your mailbox when we have news to tell.
News details - Novo Nordisk
WEBMar 8, 2024 · Novo Nordisk's commitment to the obesity and cardiovascular community is a long-term one, and we are investing significantly to build capacity to meet increasing demand. Please visit WegovySupply.com for the latest information.
News details - Novo Nordisk
WEBNews details. 12:46 PM. June 4 2021. Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials.
Novo Nordisk's Ozempic cuts risk of kidney disease progression
WEBMar 5, 2024 · Novo Nordisk ’s blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients, according to initial late-stage trial results released ...
Skip to content